The Journal of Korean Obstetrics and Gynecology (대한한방부인과학회지)

The Society of Korean Medicine Obstetrics and Gynecology (대한한방부인과학회)
권호 표지
DOI QR코드

DOI QR Code

A Study on Antibacterial Effects of Five Single Herbs Aqueous Extracts against Staphylococcus aureus

5종 단미제의 Staphylococcus aureus에 대한 in vitro 항균력 평가

  • Park, Eun-Young (Dept. of Oriental Obstetric & Gynecology, College of Oriental Medicine, Daegu Haany University) ;
  • Kim, Dong-Chul (Dept. of Oriental Obstetric & Gynecology, College of Oriental Medicine, Daegu Haany University)
  • 박은영 (대구한의대학교 한의과대학 부인과 교실) ;
  • 김동철 (대구한의대학교 한의과대학 부인과 교실)
  • Received : 2013.01.23
  • Accepted : 2013.02.08
  • Published : 2013.02.22
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The object of this study was to observe the in vitro antibacterial effects of five single(Pulsatillae Radix, Patrinae Radix, Sanguisorbae Radix, Sophorae Flos, and Sophorae Radix) aqueous herbal extracts, traditionally used for treating various gynecological diseases including mastitis in Korea, against Staphylococcus aureus. Methods: Antibacterial activities against Staphylococcus aureus of aqueous extracts of Pulsatillae Radix, PatrinaeRadix, Sanguisorbae Radix, Sophorae Flos, and Sophorae Radix were detected using standard agar microdilution methods. In addition, the effects on the bacterial growth curve were also monitored at Minimal Incubation Concentration(MIC) and $MIC{\times}2$ levels. The effects on the intracellular killing and bacterial invasion of individual test materials were also observed using murine macrophage(Raw 264.7) and human mammary gland carcinoma cell(MCF-7). Results: MIC of aqueous extracts of Pulsatillae Radix, Patrinae Radix, Sanguisorbae Radix, Sophorae Flos, and Sophorae Radix against Staphylococcus aureus were detected as $0.215{\pm}0.107$ mg/ml, $0.273{\pm}0.107$ mg/ml, $0.469{\pm}0.297$ mg/ml, $11.850{\pm}8.406$ mg/ml, and $0.664{\pm}0.546$ mg/ml, respectively. MIC of Ciprofloxacin was detected as $0.469{\pm}0.297{\mu}g/ml$ at same conditions. In addition, all five single aqueous herbal extracts were also showed marked dosage-dependent inhibition of bacterial growth. The effects of intracellular killing with Raw 264.7 and inhibition of bacterial invasion with MCF-7 cells were detected, in the order of Sophorae Flos, Pulsatillae Radix, Patrinae Radix, Sanguisorbae Radix and Sophorae Radix aqueous extracts in the present study. Conclusions: The results obtained in this study suggest that all five single aqueous herbal extracts showed antibacterial effects against Staphylococcus aureus and they also showed dosage-dependent inhibitory effects on the bacterial growth. They showed the significant intracellular killing and inhibition of bacterial invasion effects. It means, all five single aqueous herbal extracts may show potent anti-infectious effects against Staphylococcus aureus for mastitis.

Keywords

References

  1. Department of Child and Adolescent Health and Development. Mastitis: causes and management. World Health Organization(Geneva):2000. Available from URL:http://libdoc.who.int/hq/2000 /WHO_FCH_CAH_00.13_spa.pdf.
  2. Wambach KA. Lactation mastitis: a descriptive study of the experience. J Hum Lact. 2003;19:24-34. https://doi.org/10.1177/0890334402239731
  3. Nordeng H, Tufte E, Nylander G. Treatment of mastitis in general practice. Tidsskr Nor Laegeforen. 2003;123(21):3027-30.
  4. Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;78:727-31.
  5. Cassat J, et al. Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbio. 2006;152:3075-90. https://doi.org/10.1099/mic.0.29033-0
  6. Kevin P, Jaime F. Community-acquired methicillin-resistant Staphylococcus aureus:a growing public health problem. Pediatric Health. 2007;1(1):95-105. https://doi.org/10.2217/17455111.1.1.95
  7. Deresinski S. Methicillin-resistant staphylococcus aureus: an evolutionary epidemiologic and therapeutic odyssey. Clin Infect Dis. 2005;40(4):562-73. https://doi.org/10.1086/427701
  8. 최성화 등. 부산 지역 설사 환자에서 분리한 MRSA 균주의 다양성 분석. J of Life Sci. 2008;18(8):1083-9. https://doi.org/10.5352/JLS.2008.18.8.1083
  9. Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents. 2000;16:5-15. https://doi.org/10.1016/S0924-8579(00)00192-8
  10. Seral C, Van Bambeke F, Tulkens PM. Quantitative analysis of gentamicin, azithromycin, telithromycin, Ciprofloxacin, moxifloxacin and oritavancin(LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob Agents Chemother. 2003; 47:2283-92. https://doi.org/10.1128/AAC.47.7.2283-2292.2003
  11. Ackermann G, et al. Resistant to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutationsin gyrA. Antimicrob Agents Chemother. 2001;45:2348-53. https://doi.org/10.1128/AAC.45.8.2348-2353.2001
  12. Akasaka T, et al. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosaisolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother. 2001;45:2263-8. https://doi.org/10.1128/AAC.45.8.2263-2268.2001
  13. Bachoual R, et al. Single or double mutation alterations of gyrA associated with fluoroquinolone resistance in Carmpylobacter jejuni and Campylobacter coli. Microb Drug Resist. 2001;7:257-61. https://doi.org/10.1089/10766290152652800
  14. 배종국. 한방유방학. 서울:정담. 2005 :153-81.
  15. 한방여성의학 편찬위원회. 한방여성의학 II. 서울:정담. 2007:446-9.
  16. 許浚. 東醫寶鑑. 경남:동의보감출판사. 2006:681-3.
  17. Pfaller MA, et al. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother. 1990;34:1648-54. https://doi.org/10.1128/AAC.34.9.1648
  18. Janssen AM, Scheffer JJ, Baerheim SA. Antimicrobial activity of essential oils: a 1976-86 literature review. Aspects of the test methods. Planta Med. 1987; 53:395-8. https://doi.org/10.1055/s-2006-962755
  19. Tenover FC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 1998;36:1020-7.
  20. Cuffini AM, et al. Enhanced Staphylococcus aureus susceptibility to immuno-defense induced by sub-inhibitory and bactericidal concentration of imipenem. J Antimicrob Chemotherp. 1993;31:559-68. https://doi.org/10.1093/jac/31.4.559
  21. Almeida RA, et al. Staphylococcus aureus invasion of bovine mammary epithelial cells. J Dairy Sci. 1996;79 :1021-6. https://doi.org/10.3168/jds.S0022-0302(96)76454-8
  22. Menzies BE, Kourteva I. Internalisation of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immunol. 1998;66:5994-8.
  23. 정상설. 핵심유방학개론. 서울:고려의학. 1998:14-7.
  24. 신혁재. 유방염의 최신지견. 의약정보. 2011;37(1):22-7.
  25. 송병기. 한방부인과학. 서울:행림출판. 1992:273-4.
  26. 대한병리학회. 병리학. 서울:고문사. 1990:1054-5.
  27. Fass RJ. Ciprofloxacin: Best use of this new broad-spectrum antibiotic. Postgrad Med. 1990;87(8):117-31.
  28. K Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61(3) :377-92.
  29. Pispirigos K, Chrysanthopoulos K. Evaluation of cardiac subacute toxicity of Ciprofloxacin in rats using serum biochemical parameters. Arzneimittelforshung. 2001;51:582-7.
  30. Pons R, Escutia B. Ciprofloxacin-induced vasculitis with cutaneous and renal involvement. Nefrologia. 2001;21:209-12.
  31. Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and Ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res. 2001;62:704-8. https://doi.org/10.2460/ajvr.2001.62.704
  32. Williams RJ II, et al. The effect of Ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28:364-9. https://doi.org/10.1177/03635465000280031401
  33. 김인락 등. 本草學. 서울:永林社. 2007: 186-8, 205-56, 389-92, 434-47, 467-9, 478-89, 576-8, 583-5, 629-31.
  34. 김동현 등. 한방약리학. 서울:신일상사. 2006:223-5, 331-4, 369-70, 409-13.
  35. Youn HJ, et al. Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum. Vet Parasitol. 2003;116:7-14. https://doi.org/10.1016/S0304-4017(03)00154-7
  36. 성인화. 白頭翁에서 분리한 Linoleic acid 와 시약용 Linoleic acid의 Methicillin -Resistant Staphylococcus aureus와 Candida albicans에 대한 항균효과 비 .교. 대한화학요법회지. 2002;20:295-302.
  37. Jeon J, et al. Aqueous extract of the medicinal plant Patrinia villosaJuss. induces angiogenesis via activation of focal adhesion kinase. Microvasc Res. 2010;80:303-9. https://doi.org/10.1016/j.mvr.2010.05.009
  38. Xie Y, et al. Chemical composition and antioxidant activity of volatiles from Patrinia villosa Juss obtained by optimized supercritical fluid extraction. J Pharm Biomed Anal. 2008;48:796-801. https://doi.org/10.1016/j.jpba.2008.08.004
  39. Li N, et al. Studies on anti-inflammation chemical constitutes of Patrinia villosa. Zhong Yao Cai. 2008;31:51-3.
  40. 김세령, 원지혜, 김미라. 地楡 에탄올 추출물의 식품 위해성 세균에 대한 항균 활성 및 Salmonella serotype Typhimurium TA100에 대한 항돌연변이 활성 효과. 한국식품조리과학회지. 2011;27(4):17-26.
  41. Kimura M, Yamada H. Interaction in the antibacterial activity of flavonoids from Sophora japonica L. to Propionibacterium. Yakugaku Zasshi. 1984;104:340-6. https://doi.org/10.1248/yakushi1947.104.4_340
  42. Cha JD, et al. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus. Phytother Res. 2009;23:1326-31. https://doi.org/10.1002/ptr.2540
  43. Garcia I, et al. Uptake and intracellularactivity of ofloxacin isomers in human phagocytic and nonphagocytic cells. Int J Antimicrob Agents. 2000;15:201-5. https://doi.org/10.1016/S0924-8579(00)00161-8
  44. Gresham HD, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. 2000;164:3713-22. https://doi.org/10.4049/jimmunol.164.7.3713
  45. Maurin M, Raoult D. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother. 2001; 45:2977-86. https://doi.org/10.1128/AAC.45.11.2977-2986.2001
  46. Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63:174-229.
  47. Dziewanowska K, et al. Fibronectin binding protein and host cell tyrosine kinase are required for internalisation of Staphylococcus aureus by epithelial cells. Infect Immunol. 1999;67:4673-8.

Cited by

  1. 일부 살충해독유(殺蟲解毒類) 한약의 Staphylococcus aureus에 대한 시험관 내 항균 및 항염 효과 vol.27, pp.1, 2013, https://doi.org/10.15204/jkobgy2014.27.1.081